Let’s Discuss The QuidelOrtho Corporation (NASDAQ: QDEL) Stock Forecast.

In the last trading session, 1.38 million shares of the QuidelOrtho Corporation (NASDAQ:QDEL) were traded, and its beta was 0.08. Most recently the company’s share price was $29.74, and it changed around -$0.44 or -1.46% from the last close, which brings the market valuation of the company to $2.01B. QDEL currently trades at a discount to its 52-week high of $49.45, offering almost -66.27% off that amount. The share price’s 52-week low was $23.77, which indicates that the current value has risen by an impressive 20.07% since then.

QuidelOrtho Corporation stock received a consensus recommendation rating of Buy, based on a mean score of 1.90. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 3 recommended QDEL as a Hold, whereas 3 deemed it a Buy, and 1 rated it as Underweight. QuidelOrtho Corporation is expected to report earnings per share of 0.01 for the current quarter.

QuidelOrtho Corporation (NASDAQ:QDEL) trade information

Instantly QDEL has showed a red trend with a performance of -1.46% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 33.00 on recent trading dayincreased the stock’s daily price by 9.88%. The company’s shares are currently down -33.24% year-to-date, but still down -11.12% over the last five days. On the other hand, QuidelOrtho Corporation (NASDAQ:QDEL) is 7.06% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $110, which translates to bulls needing to increase their stock price by 72.96% from its current value. Analyst projections state that QDEL is forecast to be at a low of $50 and a high of $125.

QuidelOrtho Corporation (QDEL) estimates and forecasts

The year-over-year growth rate is expected to be -2.47%, down from the previous year.

Consensus estimates provided by 8 financial analysts predict the company will bring in an average of 612.36M in revenue for the current quarter. 8 analysts expect QuidelOrtho Corporation to make 694.96M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 637M and 727.1M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -3.87%. Forecasts for the next quarter put sales growth at -4.42%.

QuidelOrtho Corporation earnings are expected to increase by 28.99% in 2025, but the outlook is positive 31.81% per year for the next five years.

QDEL Dividends

QuidelOrtho Corporation’s next quarterly earnings report is expected to be released in June.

T. ROWE PRICE INVESTMENT MANAGEMENT, INC., with 14.1502% or 9.49 million shares worth $315.42 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

iShares Trust-iShares Core S&P Small-Cap ETF and T. Rowe Price Mid-Cap Growth Fund, Inc. were the top two Mutual Funds as of Apr 30, 2025 . The former held 4.0 shares worth $118.85 million, making up 5.91% of all outstanding shares. On the other hand, T. Rowe Price Mid-Cap Growth Fund, Inc. held roughly 3.27 shares worth around $97.11 million, which represents about 4.83% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.